Petra Seibold

5.0k citations
41 papers · 831 indexed · h-index 18
Topics
Cancer Risks and Factors (12 papers)Breast Cancer Treatment Studies (8 papers)Global Cancer Incidence and Screening (7 papers)

In The Last Decade

Petra Seibold

37 papers receiving 820 citations

Peers

Petra Seibold
Comparison fields: 5 of 92
  • Oncology 405
  • Molecular Biology 205
  • Cancer Research 202
  • Pulmonary and Respiratory Medicine 194
  • Radiology, Nuclear Medicine and Imaging 116
Replace Riikka Huovinen with:
Riikka Huovinen Finland
Yon‐Dschun Ko Germany
Jenna Morgan United Kingdom
Nam Sun Paik South Korea
Rex B. Mowat United States
Jong Jin Oh South Korea
Huai Liu China
Shelley M. Enger United States
Jawaid Younus Canada
María Buxó Spain
Petra Seibold relative to Riikka Huovinen Finland Riikka Huovinen's profile →
Citations per field
00.5×1.5×
Riikka Huovinen · 1×
Citations per year

Countries citing papers authored by Petra Seibold

Since Specialization
Citations

This map shows the geographic impact of Petra Seibold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Seibold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Seibold more than expected).

Fields of papers citing papers by Petra Seibold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Seibold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Seibold. The network helps show where Petra Seibold may publish in the future.

Co-authorship network of co-authors of Petra Seibold

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Seibold. A scholar is included among the top collaborators of Petra Seibold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Seibold. Petra Seibold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 1
4 0
5 1
6 15
7 4
8 11
9 3
10 12
11 14
12 10
13 6
14 45
15 18
16 50
17 23
18 58
19 35
20 29

About Petra Seibold

Petra Seibold is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 41 papers that have together received 831 indexed citations. Recurring topics across this work include Cancer Risks and Factors (12 papers), Breast Cancer Treatment Studies (8 papers) and Global Cancer Incidence and Screening (7 papers). The work is most often cited by research in Oncology (405 citations), Cancer Research (202 citations) and Pathology and Forensic Medicine (115 citations). Petra Seibold has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Jenny Chang‐Claude, Dieter Flesch‐Janys, Judith Heinz, Alina Vrieling, Nadia Obi, Karen Steindorf, Martina E. Schmidt, Odilia Popanda, Katharina Buck and Peter Schmezer. Their work appears in journals such as Nature Communications, PLoS ONE and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026